Pulse Infoframe Inc.

Our Founder & CEO Dr. Femida Gwadry-Sridhar has been invited to speak alongside other leaders of healthcare technology companies at a series of conferences being put on by the Canada-UK Chamber of Commerce at Canada House, One Nucleus and GIANT Health Event at the start of next month. Femida will serve as a panelist and speak on a variety of topics with the overarching theme of building knowledge by sharing knowledge through evidence generation. We will be sharing additional details about each speaking session in the coming weeks. You can learn more about these events below: https://lnkd.in/gEqV2Dsb - Canada-UK Chamber of Commerce https://lnkd.in/erk3WXa8 - Genesis Conference 2024 https://lnkd.in/e_SdaUjf - Discovery to Commercialisation in Rare Diseases - The Role of Real-World Evidence https://www.giant.health/ - Giant Health   #GenesisLondon24 #CanadaUK #Giant2024 #Lifescience

Illuminate Hypersomnia Adjunct Scientific Meeting speaker announcement! We're thrilled to include the following panelists: - Dr. Kiran Maski, Associate Professor at Harvard Medical School and child neurologist and sleep medicine specialist at Boston Children’s Hospital - Dr. David Plante, Associate Professor of Psychiatry and Sleep Medicine at the University of Wisconsin-Madison, where he also serves as the Medical Director of the Wisconsin Institute for Sleep and Consciousness/Wisconsin Sleep and as the Program Director of the clinical sleep medicine fellowship. - Dr. Anne Marie Morse, chair of child neurology and pediatric sleep medicine, as well as the program director for the child neurology residency program at Geisinger Medical Center - Dr. Lucie Barateau, Associate Professor at the Sleep Unit of Montpellier University Hospital, National Reference Center for Narcolepsy and Rare Hypersomnias in France - with Kim McCleary as the moderator On February 13, 2025 from 12:00 p.m. – 2:00 p.m. EST, they will join this virtual scientific session to share insights in a panel discussion - Approaches to Better Defining and Measuring Brain Fog in IH. Don't miss this opportunity to hear them and many more global experts as they tackle key research challenges in idiopathic hypersomnia (IH). This meeting addresses priorities identified by the IH patient community through the ground-breaking Illuminate Hypersomnia Externally Led Patient-Focused Drug Development meeting and survey. Learn more and register today: https://lnkd.in/ezvDE-vr #IHPFDD #IlluminateIH #idiopathichypersomnia #livingwithIH #livingwithidiopathichypersomnia #idiopathichypersomnolence #PFDD #patientfocused #sleepconsortium #thisisIH

Exciting news! Our team will be presenting posters at the 2025 WORLD Symposium, sharing insights into real-world evidence generation for lysosomal storage disorders. These presentations underscore the transformative impact of collaborative, data-driven solutions in advancing research and improving patient outcomes. Discover more about our work and what we’ll be sharing at WORLD 2025: https://lnkd.in/ep73wr7N #WORLD2025 #RareDiseases #RealWorldEvidence #DataDrivenCare #PulseInfoframe

CACNA1C-related disorders go beyond Timothy Syndrome, including developmental delay, intellectual disability, epilepsy, and psychiatric conditions, even without cardiac symptoms. In this film clip, Dr. Rebecca Levy from Stanford University School of Medicine, who is also a member of our Scientific Advisory Board, acknowledges the range of symptoms associated with CACNA1C variants. Have you watched the whole film? (link in the comments below). We have entered it into the Smiley Charity Film Awards, and we would greatly appreciate your vote to help us advance to the next stage of judging. #RareDiseases #Research #CACNA1C #TimothySyndrome #LongQT8 #CFA25 #CharityFilmAwards

Our Founder & CEO, Dr. Femida Gwadry-Sridhar, had an incredible experience speaking at the Startup Spotlight session during the GIANT Health Event. It was a great opportunity to highlight innovation and engage with brilliant minds shaping the future of healthcare. A big thank you to Giant Health for creating such a vibrant platform for collaboration and ideas! #GIANT2024 #RealWorldData

Among the exceptional One Nucleus #GenesisLondon2024 Fringe Events is "Discovery to Commercialisation in Rare Diseases - The Role of Real-World Evidence (RWE)" hosted by J A Kemp. This discussion will delve into how RWE can enhance drug discovery, clinical trial innovation, and commercialisation with a focus on rare diseases as a model, offering insights applicable across the therapeutic landscape. Join an outstanding line-up of experts Tony Jones (One Nucleus), Ron (Roni) A. Jortner (Aspire Biosciences), Femida Gwadry-Sridhar (Pulse Infoframe Inc.), Ravi Srinivasan (J A Kemp) and Julie Adrian (FINN Partners) as they explore how effectively leveraging RWE can bring groundbreaking treatments to patients. Seats are limited—learn more and secure your spot here: https://lnkd.in/ePNaXY4c

It was a pleasure for our Founder & CEO Dr. Femida Gwadry-Sridhar to be part of a panel at the Canada-UK Chamber of Commerce Annual Health & Life Sciences Forum: Real-World Evidence & Big Data in Healthcare: a Canada-UK Discussion. Femida was joined by other industry experts to discuss "Risk, Regulations, and Rewards: Discussion on How and Where We Use Big Data." Thank you to the Canada-UK Chamber of Commerce for hosting another excellent event! #CanadaUK #MachineLearning #AI #LifeScience #BigData #RealWorldData

What’s driving the future of health-tech innovation? Find out at GIANT Health Event 2024, where Pulse Infoframe Founder and CEO, Dr. Femida Gwadry-Sridhar, will speak on the "Startup Spotlight" panel. In this dynamic session will showcase the importance of knowledge translation by leveraging real-world data to help accelerate the adoption of tech innovation in healthcare. Giant Health is the UK’s premier NHS innovation festival, featuring 6+ immersive shows, 100s of world-class speakers, and groundbreaking start-up pitches. It’s the go-to event for networking, learning, and celebrating the health-tech breakthroughs shaping tomorrow. Learn more about the event here: https://www.giant.health/ #GIANT2024 #HealthTech #DigitalHealth #NHS 

Among the exceptional One Nucleus #GenesisLondon2024 Fringe Events is "Discovery to Commercialisation in Rare Diseases - The Role of Real-World Evidence (RWE)" hosted by J A Kemp. This discussion will delve into how RWE can enhance drug discovery, clinical trial innovation, and commercialisation with a focus on rare diseases as a model, offering insights applicable across the therapeutic landscape. Join an outstanding line-up of experts Tony Jones (One Nucleus), Ron (Roni) A. Jortner (Aspire Biosciences), Femida Gwadry-Sridhar (Pulse Infoframe Inc.), Ravi Srinivasan (J A Kemp) and Julie Adrian (Alverium Health) as they explore how effectively leveraging RWE can bring groundbreaking treatments to patients. Seats are limited—learn more and secure your spot here: https://lnkd.in/ePNaXY4c

How can we harness the power of Real-World Evidence (RWE) to transform clinical trials and rare disease treatments? Dr. Femida Gwadry-Sridhar, Founder and CEO of Pulse Infoframe, will be speaking at the Genesis Fringe Event: Discovery to Commercialization in Rare Diseases on "The Standardization of Data Collection and Sharing to Deliver Useful RWE to Inform Clinical Trial Design." She will share insights on tackling challenges in RWE standardization to enhance innovation and drive better outcomes for patients. This One Nucleus event explores how RWE can accelerate drug discovery, improve trial designs, and drive commercialization in rare diseases, offering lessons for the broader healthcare landscape. You can learn more about the event here: https://lnkd.in/e_SdaUjf #LifeScience #Genesis24 #OneNucleus #DrugDevelopment #Pharma #GenesisLondon24